Search Results - "Routh, Josh"

BRAF mutation classes and co-occurring mutations in NSCLC by Niu, Jiaxin, Flannery, Cynthia A., Hall, David W., Hoag, Jess W., Therala, Nishitha, Kemkes, Ariane C., Routh, Josh, De La O, Jean-Paul, Macera, Lisa, Thakkar, Snehal Govind

“…9083 Background: Targeted therapy against unique molecular drivers has revolutionized non-small cell lung cancer (NSCLC) treatment. BRAF mutations, present in…”
Get full text

Molecular profiling to identify potential therapeutic targets in hepatocellular carcinoma by Kundranda, Madappa N., Routh, Josh, Kemkes, Ariane C., Turner, Michelle, Therala, Nishitha, Hall, David W., Flannery, Cynthia A., Evans, Mark C., De La O, Jean-Paul, Thakkar, Snehal Govind

“…Abstract only 471 Background: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is often diagnosed at an advanced stage with…”
Get full text

Age-associated mutations in RAS -mutated versus RAS- nonmutated metastatic colorectal cancer by Kundranda, Madappa N., Kemkes, Ariane C., Routh, Josh, De La O, Jean-Paul, Evans, Mark C., Flannery, Cynthia A., Hall, David W., Therala, Nishitha, Turner, Michelle, Thakkar, Snehal Govind

“…Abstract only 171 Background: Mutational profiling is recommended for selecting targeted therapy for metastatic colorectal cancer (mCRC). Evidence suggests…”
Get full text